|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 1999;68:2058
© 1999 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, Harper Hospital, 3990 John R, Suite 2102, Detroit, MI, USA 48201
e-mail: pass@cardiology.harper.wayne.edu
Invited commentary
There are a few papers every year that can potentially revolutionize the care of patients with lung cancer. This paper is one of them and should be listed as one of the classics from The Annals of Thoracic Surgery. Moreover, to have conceived the idea of bone marrow biopsy as a potential prognostic indicator in lung cancer in 1989 at a time when even "systemic mediastinal lymphadenectomy" was not even considered standard underscores the vision and genius of this thoracic group.
The findings in this manuscript that two or more micrometastases found on numerous bone-marrow biopsies is an independent predictor of overall survival from completely resected patients with lung cancer is, in my opinion, going to change our whole approach to the determination of the M status
Related Article
Ann. Thorac. Surg. 1999 68: 2053-2058.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |